How to optimize the sequential use of novel therapeutics in metastatic prostate cancer patients? Response should be found in prostate cancer tissue

Tumour Biol. 2014 Aug;35(8):7391-2. doi: 10.1007/s13277-014-2145-0. Epub 2014 May 30.

Authors

Edoardo Francini¹, Giandomenico Roviello

Affiliation

¹ Medical Oncology Unit, Policlinico Umberto I Hospital, University of Rome, Rome, Italy.

PMID: 24874054
DOI: 10.1007/s13277-014-2145-0

No abstract available

Publication types

Comment

MeSH terms

Androstenols / therapeutic use*
Antineoplastic Agents / therapeutic use*
Humans
Male
Phenylthiohydantoin / analogs & derivatives*
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Taxoids / therapeutic use*

Substances

Androstenols
Antineoplastic Agents
Taxoids
Phenylthiohydantoin